Variant report
Variant | esv3421296 |
---|---|
Chromosome Location | chr5:68926496-68931794 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:78)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL11A | chr5:68929807-68929986 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr5:68926064-68926713 | K562 | blood: | n/a | n/a |
3 | CTCF | chr5:68929341-68929391 | Kidney_OC | kidney: | n/a | n/a |
4 | EBF1 | chr5:68928679-68928891 | GM12878 | blood: | n/a | n/a |
5 | FOSL2 | chr5:68929549-68929799 | HepG2 | liver: | n/a | n/a |
6 | FOXP2 | chr5:68930535-68930850 | PFSK-1 | brain: | n/a | n/a |
7 | FOXP2 | chr5:68929790-68930211 | PFSK-1 | brain: | n/a | n/a |
8 | FOXP2 | chr5:68929029-68929480 | PFSK-1 | brain: | n/a | n/a |
9 | GABPA | chr5:68929617-68929721 | Hela-S3 | cervix: | n/a | n/a |
10 | GABPA | chr5:68929546-68929739 | Hela-S3 | cervix: | n/a | n/a |
11 | GABPA | chr5:68930359-68930595 | Hela-S3 | cervix: | n/a | n/a |
12 | GABPA | chr5:68930033-68930246 | Hela-S3 | cervix: | n/a | n/a |
13 | GABPA | chr5:68930007-68930160 | Hela-S3 | cervix: | n/a | n/a |
14 | JUND | chr5:68930384-68930620 | HepG2 | liver: | n/a | n/a |
15 | PAX5 | chr5:68930331-68930663 | GM12878 | blood: | n/a | n/a |
16 | PAX5 | chr5:68930014-68930176 | GM12878 | blood: | n/a | n/a |
17 | PAX5 | chr5:68928701-68928877 | GM12878 | blood: | n/a | n/a |
18 | PAX5 | chr5:68930365-68930625 | GM12878 | blood: | n/a | n/a |
19 | PAX5 | chr5:68929552-68929761 | GM12878 | blood: | n/a | n/a |
20 | PAX5 | chr5:68931176-68931370 | GM12878 | blood: | n/a | n/a |
21 | PBX3 | chr5:68929623-68929726 | GM12878 | blood: | n/a | n/a |
22 | PBX3 | chr5:68929846-68929968 | GM12878 | blood: | n/a | n/a |
23 | PBX3 | chr5:68928803-68928914 | GM12878 | blood: | n/a | n/a |
24 | POLR2A | chr5:68928560-68930691 | GM12892 | blood: | n/a | n/a |
25 | POLR2A | chr5:68927089-68927273 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | POLR2A | chr5:68929180-68929364 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | POLR2A | chr5:68928623-68929482 | GM12878 | blood: | n/a | n/a |
28 | POLR2A | chr5:68930383-68930609 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr5:68929228-68929431 | GM12878 | blood: | n/a | n/a |
30 | POLR2A | chr5:68929989-68930177 | H1-hESC | embryonic stem cell: | n/a | n/a |
31 | POLR2A | chr5:68931380-68931798 | GM12878 | blood: | n/a | n/a |
32 | POLR2A | chr5:68928701-68928869 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | POLR2A | chr5:68928572-68930676 | GM12892 | blood: | n/a | n/a |
34 | POLR2A | chr5:68931158-68931952 | GM12878 | blood: | n/a | n/a |
35 | POLR2A | chr5:68928685-68928976 | GM12878 | blood: | n/a | n/a |
36 | POLR2A | chr5:68929979-68930181 | GM12878 | blood: | n/a | n/a |
37 | POLR2A | chr5:68927097-68927268 | GM12878 | blood: | n/a | n/a |
38 | POLR2A | chr5:68931184-68931438 | GM12878 | blood: | n/a | n/a |
39 | POLR2A | chr5:68931168-68931379 | GM12878 | blood: | n/a | n/a |
40 | POLR2A | chr5:68927122-68927250 | A549 | lung: | n/a | n/a |
41 | POLR2A | chr5:68928710-68928929 | H1-hESC | embryonic stem cell: | n/a | n/a |
42 | POLR2A | chr5:68930379-68930618 | H1-hESC | embryonic stem cell: | n/a | n/a |
43 | POLR2A | chr5:68929543-68929786 | GM12878 | blood: | n/a | n/a |
44 | POLR2A | chr5:68928181-68928481 | GM12878 | blood: | n/a | n/a |
45 | POLR2A | chr5:68927037-68927328 | GM12878 | blood: | n/a | n/a |
46 | POLR2A | chr5:68929566-68929783 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | POLR2A | chr5:68928580-68930732 | GM12878 | blood: | n/a | n/a |
48 | POLR2A | chr5:68930068-68930751 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | POLR2A | chr5:68931081-68931809 | GM12892 | blood: | n/a | n/a |
50 | POLR2A | chr5:68929546-68929800 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250138 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201733573 | chr5:68927608-68927609 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs367926259 | chr5:68927623-68927624 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570743173 | chr5:68927655-68927656 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs538065674 | chr5:68927664-68927665 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79147590 | chr5:68927676-68927677 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374188899 | chr5:68927693-68927694 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368904163 | chr5:68927701-68927702 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568202620 | chr5:68927712-68927713 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs372166417 | chr5:68927743-68927744 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78541768 | chr5:68927746-68927747 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535547476 | chr5:68927766-68927767 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553541293 | chr5:68927768-68927769 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201031170 | chr5:68927841-68927842 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201967684 | chr5:68927845-68927846 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572031548 | chr5:68927863-68927864 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545449469 | chr5:68927872-68927873 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558066832 | chr5:68927978-68927979 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375884043 | chr5:68927988-68927989 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576308900 | chr5:68927989-68927990 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201046606 | chr5:68928280-68928281 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs371303501 | chr5:68928365-68928366 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs543646389 | chr5:68928420-68928421 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs62374275 | chr5:68928433-68928434 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs561953661 | chr5:68928501-68928502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200108570 | chr5:68928609-68928610 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs201118284 | chr5:68928618-68928619 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs202054364 | chr5:68928678-68928679 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs529417586 | chr5:68928683-68928684 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs200309676 | chr5:68928699-68928700 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs373173173 | chr5:68928711-68928712 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs375465564 | chr5:68928712-68928713 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs80104476 | chr5:68928734-68928735 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs541535307 | chr5:68928763-68928764 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs200177040 | chr5:68928780-68928781 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs559552701 | chr5:68928787-68928788 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs533397752 | chr5:68928801-68928802 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs551777741 | chr5:68928826-68928827 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs570808196 | chr5:68928835-68928836 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs377495071 | chr5:68928930-68928931 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs370395111 | chr5:68928931-68928932 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs202120351 | chr5:68928934-68928935 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs200447535 | chr5:68929006-68929007 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs201113383 | chr5:68929009-68929010 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs200967433 | chr5:68929011-68929012 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs200704023 | chr5:68929013-68929014 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs377581375 | chr5:68929078-68929079 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs201180084 | chr5:68929117-68929118 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs199643856 | chr5:68929118-68929119 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs531627218 | chr5:68929152-68929153 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs550061259 | chr5:68929157-68929158 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ovarian cancer | 21781307 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pseudo-TORCH syndrome | 20727516 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 21865298 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Obesity | 21131291 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21364760 | CNVD |
Disease | 19212409 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68922800-68927600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr5:68926600-68929000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
3 | chr5:68926600-68929000 | Weak transcription | Primary T cells from cord blood | blood |
4 | chr5:68926600-68929000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr5:68926600-68929000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr5:68926600-68929000 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
7 | chr5:68926600-68929000 | Weak transcription | Brain Germinal Matrix | brain |
8 | chr5:68926600-68929000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
9 | chr5:68926600-68929000 | Weak transcription | Fetal Intestine Large | intestine |
10 | chr5:68926600-68929000 | Weak transcription | Fetal Intestine Small | intestine |
11 | chr5:68926600-68929000 | Weak transcription | Fetal Stomach | stomach |
12 | chr5:68926600-68929000 | Weak transcription | Ovary | ovary |
13 | chr5:68927000-68927800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr5:68927600-68928200 | Strong transcription | Primary neutrophils fromperipheralblood | blood |
15 | chr5:68927800-68928000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr5:68927800-68928000 | Enhancers | Brain Anterior Caudate | brain |
17 | chr5:68928000-68928200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr5:68928200-68929800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |